Passive acquisition of anti-Staphylococcus aureus antibodies by newborns via transplacental transfer and breastfeeding, regardless of maternal colonization

OBJECTIVE: To investigate the transmission of anti-Staphylococcus aureus (Sa) IgG, IgG1 and IgG2 via placental transfer and the transfer of IgA via the colostrum according to maternal Sa carrier status at delivery. METHODS: We evaluated anti-Sa IgG, IgG1 and IgG2 in maternal and cord sera and IgA in colostrum from a case (n=49, Sa+) and a control group (n=98, Sa-). RESULTS: Of the 250 parturients analyzed for this study, 49 were nasally colonized with S. aureus (prevalence of 19.6%). Ninety-eight non-colonized subjects were selected for the control group. The anti-Sa IgG, IgG1 and IgG2 levels and the IgG avidity indexes in the maternal and cord sera did not differ between the groups, with a low transfer ratio of anti-Sa IgG to the newborns in both groups. The anti-Sa IgG2 titers were significantly higher than the IgG1 titers in the maternal and cord sera. Inversely, the transfer ratios were higher for anti-Sa IgG1 compared with IgG2; however, no differences between the groups were detected. The Sa-specific IgA levels and avidity indexes in the colostrum were equivalent between groups. CONCLUSIONS: Maternal Sa nasal colonization at delivery is not associated with higher antibody levels in the mother or newborns. The high titers of anti-Sa IgG2 found in the cord serum indicate a greater reactivity with non-protein antigens, which may further contribute to the susceptibility to staphylococcal infections at birth. The presence of IgA in the colostrum with avidity to S. aureus reinforces the importance of breastfeeding shortly after birth.

Desenvolvimento de um marcador molecular para o diagnóstico e monitoramento da sepse neonatal bacteriana / Development of a molecular marker for diagnosis and monitoring of neonatal bacterial sepsis

A sepse bacteriana constitui a causa mais frequente de óbitos neonatais, e seu diagnóstico é complexo devido à inexistência de um teste laboratorial definitivo. O presente estudo desenvolveu uma técnica de amplificação quantitativa (qPCR) do gene 16S rDNA de bactérias tanto para o diagnóstico de sepse neonatal, quanto para avaliar se a qPCR é capaz de monitorar o tratamento. Para ser recrutado o RN deveria apresentar ao menos dois sinais/sintomas sugestivos de sepse, e dois parâmetros laboratoriais alterados. Amostras de sangue foram colhidas no tempo zero (suspeita de sepse), 48 horas e sete dias após o início da antibioticoterapia. Foram analisados 73 RN (21 RNT e 52 RNPT) com suspeita de sepse neonatal. A hemocultura foi positiva em 32 RN (43,8% - sepse confirmada) e negativa em 41 (56,2% - sepse clínica), enquanto a qPCR foi positiva em 65 RN (89%) e negativa em oito casos (11%). Dentre os 32 RN com sepse confirmada (11 RNT e 21 RNPT), neutrofilia foi encontrada em 22 (68,75%), CRP elevada em 21 (65,62%), plaquetopenia em 15 (46,87%) e leucopenia em 14 (43,75%). Foram analisadas 200 amostras dos 73 casos suspeitos, considerando os três tempos de coleta, resultando em 36 hemoculturas positivas (18,0%) e 135 qPCR positivas (67,5%). Nas 36 hemoculturas positivas houve 38 isolamentos. Bactérias Gram-positivas foram encontradas em 32 amostras (84,21%) e Gram-negativas em seis (15,78%). Staphylococcus coagulase negativa predominou dentre as Gram-positivas (75,0%). No grupo de 32 RN com sepse confirmada a qPCR foi positiva em 30 (30/32 - 93,7%). Em 14 casos (47%) a qPCR antecipou o diagnóstico de sepse quando comparada à hemocultura e foi positiva no tempo zero em 22 casos (68,75%), enquanto a hemocultura foi positiva em 11. Dos 41 casos de sepse clínica, a qPCR foi positiva em 35 (85,4%); em 26 casos (74,3%) já no tempo zero. O teste de McNemar encontrou discordância entre os resultados das hemoculturas e qPCR (p<0,0001, IC de 95%), indicando...

Bacterial sepsis constitutes one of the most frequent causes of neonatal deaths and its diagnosis is difficult due to the lack of a definitive laboratorial approach. The present study developed a bacterial 16S rDNA-based quantitative real time polymerase chain reaction (qPCR) both to the diagnosis of neonatal sepsis and to evaluate if qPCR is capable of monitoring antimicrobial treatment. For enrollment, the newborn (NB) should present, at least, two signs/symptoms suggestive of sepsis, and two abnormal laboratory parameters. Blood samples were collected on day zero (suspected sepsis), 48 hours and 7 days after the initiation of antibiotic therapy. Seventy-three newborns with suspected sepsis were recruited (21 term NB and 52 preterm NB), blood culture was positive in 32 (43.8% - confirmed sepsis) and negative in 41 (56.2% - clinical sepsis), while qPCR was positive in 65 (89.0%) and negative in 8 cases (11.0%). Considering the group of 32 NB with confirmed sepsis (11 TNB and 21PTNB), qPCR was positive in 30 (30/32 - 93.7%). Neutrophilia was found in 22 NB (68.75%), elevated CRP in 21 (65.62%), thrombocytopenia in 15 (46.87%) and leukopenia in 14 (43.75%). Of the 73 cases, taking into account the three collected samples (day zero, 48h and 7 days), 200 samples were analyzed, with 36 positive blood culture (18.0%) and 135 positive qPCR (67.5%). Of the 36 positive blood cultures, there were 38 bacterial isolations. Gram-positive bacteria were found in 32 samples (84.21%) and Gram-negative in 6 (15.78%). Coagulase-negative Staphylococcus was predominant in the Grampositive group (75.0%). In 14 cases, qPCR anticipated the diagnosis when compared with blood culture, and was positive in 22 cases on day zero (68.75%), whereas blood culture was positive in 11. Among the 41 cases of clinical sepsis, qPCR was positive in 35 (85.4%); of these 26 (74.3%) on day zero. McNemar test found discordance between the results of blood cultures and qPCR (p < 0.0001, CI of 95%)...

Avaliação do Serviço de Referência em Triagem Neonatal para hipotireoidismo congênito e fenilcetonúria no Estado de Mato Grosso, Brasil / Evaluation of the Neonatal Screening Program for congenital hypothyroidism and phenylketonuria in the State of Mato Grosso, Brazil

OBJETIVO: Avaliar o Serviço de Referência em Triagem Neonatal para hipotireoidismo congênito e fenilcetonúria no Estado de Mato Grosso. MÉTODOS: Estudo transversal, utilizando-se dados secundários dos exames realizados no período de janeiro de 2003 a dezembro de 2004. RESULTADOS: Foram feitos 66.337 testes de triagem com uma cobertura populacional inferior a 70%. A prevalência de fenilcetonúria foi de 1:33.068 nascidos vivos, e de hipotireoidismo congênito foi de 1:9.448 nascidos vivos. Apenas 22% das amostras foram coletadas na idade recomendada; a maioria realizou o teste de triagem entre 8 e 30 dias de vida. A mediana da idade na coleta do teste foi de 12 dias. Verificou-se que o serviço teve dificuldades na reconvocação dos casos suspeitos e dificuldades financeiras na obtenção dos insumos laboratoriais. CONCLUSÕES: A idade na coleta e o atraso na fase de confirmação diagnóstica foram os principais motivos para o atraso do início do tratamento dos casos detectados pelo serviço.

OBJECTIVE: To evaluate the Reference Center for Neonatal Screening for congenital hypothyroidism and phenylketonuria for the State of Mato Grosso. METHOD: Cross-sectional study using secondary data of screening tests carried out from January 2003 to December 2004. RESULTS: 66,337 exams were conducted with population coverage of less than 70%. The prevalence of phenylketonuria was 1:33,068 live births and of congenital hypothyroidism was 1:9,448 live births. Only 22% of the samples were collected at the recommended ag, and most of the samples were collected between the ages of 8 and 30 days. The median age at collection was 12 days. It was observed that the service had difficulties in recalling suspected cases and financial difficulties in obtaining laboratorial reagents. CONCLUSIONS: The age at the time of collection and the delay at the diagnostic confirmation stage were the principal reasons for the delay in the initiation of treatment of the cases detected by the service.